Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Yohimbe is an herbal supplement derived from the bark of the West African evergreen tree Pausinystalia yohimbe[3][4][5]. It has a long-standing traditional use as an aphrodisiac and for the treatment of erectile dysfunction. The active alkaloid in yohimbe bark is yohimbine, which acts primarily as an alpha-2 adrenergic receptor antagonist—blocking inhibitory presynaptic receptors and thereby increasing neurotransmitter release, including norepinephrine[1][6]. This leads to increased sympathetic activity, vasodilation in genital tissues, and effects on mood, anxiety, and sexual arousal[1][6]. Yohimbe is also marketed for weight loss, athletic performance, and as a stimulant, though there is limited clinical evidence for these uses and significant safety concerns exist, especially with variable alkaloid content in supplements[2][3][4][5][7].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on yohimbe.